Home Nav
Nextech Invest Logo

Kevin Huang

Alfred Scheidegger

Kevin Huang is an M.D. Candidate in the Pathways program at Harvard Medical School. He graduated magna cum laude and Phi Beta Kappa from Yale University in 2018 with a B.S. and distinction in Molecular, Cellular and Developmental Biology (Intensive). He has experience working in life sciences consulting as well as startup business development, and he has conducted translational research on novel targeted therapy combinations in lung cancer as well as basic science research on colon cancer metabolism. 

 

Personalized Oncology 2019 conference

23.06. – 25.06.2019

Basel, Switzerland

  • 24.07.2019

    Kura Oncology’s Menin-MLL Inhibitor KO-539 Receives...

  • 18.07.2019

    Blueprint Medicines Announces European Medicines Agency...

  • 15.07.2019

    Neon Therapeutics ’ Personal Neoantigen Vaccine Study...

Close

Newsletter Registration

Please fill in the subscription form completely. If you wish to modify your personal data or to change/cancel your newsletter subscription, this is possible at any time.

A link to your subscription profile can be found in every newsletter email.

Preview

* Compulsory fields

Close

Newsletter Registration

Your eMail have been successfully registered.

Close